Wetzstein, Nils http://orcid.org/0000-0002-5589-4668
Hügel, Christian
Wichelhaus, Thomas A.
Hogardt, Michael
Eickmeier, Olaf
Küpper-Tetzel, Claus-Philippe
Kann, Gerrit
Just-Nübling, Gudrun
Stephan, Christoph
Wolf, Timo
Article History
Received: 13 September 2018
Accepted: 2 May 2019
First Online: 15 May 2019
Compliance with ethical standards
:
: Nils Wetzstein, Thomas Wichelhaus, Michael Hogardt, Olaf Eickmeier, Gerrit Kann and Gudrun Just-Nübling declare that they have no conflict of interest. Christian Hügel has received congress fees and travel expenses from Gilead and Novartis. Claus-Philippe Küpper-Tetzel reports personal fees from Gilead, Janssen and Abbvie. Christoph Stephan reports personal honorary fees from scientific advisory board activities for pharmaceutical companies (MSD, Gilead, ViiV, Janssen Cilag) and travel grants for participation in medical conferences (BMS, Gilead, Janssen). Timo Wolf reports to have received lecture fees and travel grants by Janssen, Gilead and Merck Sharp Dome. All outside the submitted work.